Federal Supply Schedule 36F79724D001E
- Not listed
- Phathom Pharmaceuticals, Inc. (UEI: KPGYDW3H7ZW6) was awarded a Federal Supply Schedule multiple-award contract by the Veterans Integrated Service Network 12, a civilian component of the Department of Veterans Affairs, to supply drugs, pharmaceuticals, and hematology-related products under Federal Supply Classification code 65 I B. The contract, awarded July 1, 2024, carries a ceiling value of $250,000 and extends through June 30, 2029. This indefinite delivery vehicle operates without...
- The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Tetraphase Pharmaceuticals Inc., a for-profit organization and subsidiary of La Jolla Pharmaceutical Company. The contract is for the procurement of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract is a multiple-award, unrestricted (no set-aside) vehicle with...
- This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Agepha Pharma USA LLC, a foreign-owned, self-certified small disadvantaged business and woman-owned small business. The contract, under FSS Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, has a ceiling value of $25,000.00 and a period of performance through June 14, 2024. The purpose of this interim agreement is to provide the VA with access to a variety of pharmaceutical...
- Averitas Pharma, Inc. has been awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) to provide drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract was awarded on September 29, 2025, with a ceiling value of $19.24 million and extends through September 28, 2030. This is an indefinite delivery, indefinite...
- This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Axsome Therapeutics Inc., provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The $25,000 contract has a period of performance through February 28, 2023. As a multiple award FSS, this contract allows for orders to be placed by any federal agency. The contract does not utilize any set-asides. This interim agreement under the FSS facilitates the...
- Analog Pharma, Inc. has been awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule to supply drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs. The contract was awarded on September 29, 2025, with a ceiling value of $734,290.00 and a performance period extending through September 28, 2030. This award utilizes no...
- This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Vifor Pharma Inc., provides for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $85,200,000 and a period of performance extending to February 28, 2028. As a Federal Supply Schedule contract, this vehicle allows for the efficient procurement of the specified medical and pharmaceutical products by federal agencies, including...
- Nobelpharma America, LLC, a foreign-owned, self-certified small disadvantaged business, was awarded a multiple-award Federal Supply Schedule (FSS) contract by the Department of Veterans Affairs, Veterans Integrated Service Network 12 on May 15, 2023. This Pharmaceuticals and Drugs contract (FSS-61-IB) falls under Federal Supply Class 65 I B and authorizes the delivery of pharmaceutical and hematology-related products to Veterans Affairs facilities nationwide. The contract carries a ceiling value...
- This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is a $200,000.00 interim agreement with Amarin Pharma, Inc. to provide drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 IB. The contract has an ultimate completion date of August 30, 2024 and was awarded on March 5, 2024 without any set-aside requirements. The purpose of this multiple-award FSS contract is to...
- 36F79724D001EFederal Supply Schedule
- Blanket Purchase Agreements
Phathom Pharmaceuticals, Inc. has been awarded a Federal Supply Schedule (FSS) contract IDV by the Department of Veterans Affairs (VA) to provide drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract, awarded to the for-profit manufacturer of goods, has a ceiling value of $25,000 and a period of performance from January 2, 2024, to June 30, 2024. This is an interim agreement to enable the VA's Veterans Integrated Service Network 12 to issue task orders for specific pharmaceutical and hematology items as needed, streamlining the procurement process through pre-negotiated pricing and terms. The company also holds two additional FSS contract IDVs with the VA, one valued at $250,000 from July 1, 2024, to June 30, 2029, and another $25,000 interim agreement. These multiple-award contracts allow the VA to efficiently acquire critical medical products to support healthcare services for veterans. The absence of set-asides indicates that Phathom Pharmaceuticals, Inc. competed for these opportunities in the open market, demonstrating its capability to meet federal contracting requirements for supplying pharmaceutical and hematology-related products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Supplemental Agreement for work within scope | $0 | 5/28/24 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 3/20/24 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 2/27/24 | |
| Not listed | Not listed | $0 | 12/14/23 |